NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free ESTA Stock Alerts $48.54 -0.41 (-0.84%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$45.98▼$48.9550-Day Range$35.80▼$55.3852-Week Range$16.96▼$73.00Volume212,618 shsAverage Volume424,553 shsMarket Capitalization$1.33 billionP/E RatioN/ADividend YieldN/APrice Target$55.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Establishment Labs alerts: Email Address Establishment Labs MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside13.3% Upside$55.00 Price TargetShort InterestBearish21.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.68Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.58) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.09 out of 5 starsMedical Sector785th out of 908 stocksSurgical Appliances & Supplies Industry18th out of 18 stocks 2.5 Analyst's Opinion Consensus RatingEstablishment Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEstablishment Labs has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted21.54% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 0.81%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ESTA. Previous Next 2.6 News and Social Media Coverage News SentimentEstablishment Labs has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Establishment Labs this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have not sold or bought any company stock.Percentage Held by Insiders11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.58) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -15.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -15.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 68.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Establishment Labs Stock (NASDAQ:ESTA)Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Read More ESTA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ESTA Stock News HeadlinesApril 24, 2024 | businesswire.comEstablishment Labs to Announce First Quarter 2024 Financial Results on May 8April 21, 2024 | americanbankingnews.comEstablishment Labs (NASDAQ:ESTA) Shares Down 5.3% April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 20, 2024 | msn.comOKX Ventures partners with OnePiece Labs, Merlin Chain, and Franklin TempletonApril 17, 2024 | msn.comEstablishment Labs Holdings (ESTA) Price Target Increased by 10.70% to 61.54April 17, 2024 | finance.yahoo.comEstablishment Labs Announces Participation in The Aesthetic Meeting 2024April 17, 2024 | businesswire.comEstablishment Labs Announces Participation in The Aesthetic Meeting 2024April 16, 2024 | msn.comNPR suspends editor who claimed left-wing bias at outlet had ‘lost America’s trust’April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 12, 2024 | msn.comUMass Chan unveils first lab to monitor AI use in health care simulationsApril 10, 2024 | finance.yahoo.comLab-Grown Diamonds Market Set for Explosive Growth - The Future is HereApril 10, 2024 | msn.com'Mini kidneys' reveal new insights into metabolic defects in polycystic kidney diseaseApril 10, 2024 | msn.comBeach Haven kidnapping: Police raid Clevedon property looking for Ralph Park, find clandestine drug labApril 4, 2024 | msn.comCentre’s law to regulate labs to remain in force, HC toldApril 4, 2024 | msn.comHC happy over Delhi govt’s decision to implement Centre’s law to regulate clinical establishmentsApril 3, 2024 | msn.comNew Mexico chefs, food establishments named as 2024 James Beard Award finalistsApril 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)April 1, 2024 | markets.businessinsider.comKey Takeaways From Establishment Labs Hldgs Analyst RatingsApril 1, 2024 | tmcnet.comDeepcoin Labs Will Be Sponsoring Hong Kong Web3 Festival 2024March 29, 2024 | finance.yahoo.comMoomoo Announces the Moomoo Foundation Establishment, Hosts Financial Literacy Event with NYU's Economic SocietyMarch 29, 2024 | news.yahoo.comOhio's first infused coffee shop lounge opens in DaytonMarch 20, 2024 | markets.businessinsider.comEstablishment Labs Poised for Robust Growth with Motiva Expansion and Upcoming Market EntriesMarch 15, 2024 | markets.businessinsider.comBNB Chain Looks to Expand L2 Ecosystem; Introduces RaaS to Streamline Establishment of New L2 BlockchainsMarch 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP PreparednessMarch 12, 2024 | msn.comUnion Minister Rajeev Chandrasekhar Announces 10 AI Labs in Thiruvananthapuram ConstituencyMarch 12, 2024 | msn.com10 AI labs in Thiruvananthapuram colleges to establish soonMarch 12, 2024 | msn.comRajeev Chandrasekhar announces 10 AI labs in Thiruvananthapuram collegesSee More Headlines Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today4/25/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:ESTA CUSIPN/A CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees908Year FoundedN/APrice Target and Rating Average Stock Price Target$55.00 High Stock Price Target$65.00 Low Stock Price Target$47.00 Potential Upside/Downside+13.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-47.53% Pretax Margin-47.58% Return on Equity-357.81% Return on Assets-30.37% Debt Debt-to-Equity Ratio10.26 Current Ratio3.06 Quick Ratio1.67 Sales & Book Value Annual Sales$165.15 million Price / Sales8.07 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book68.37Miscellaneous Outstanding Shares27,460,000Free Float24,319,000Market Cap$1.33 billion OptionableOptionable Beta1.24 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Juan Jose Chacon Quiros (Age 52)Founder, CEO & Executive Director Comp: $913.37kMr. Rajbir Singh Denhoy (Age 54)Chief Financial Officer Comp: $570.29kMr. S. Ross Mansbach (Age 57)General Counsel & Chief Compliance Officer Comp: $379.53kMr. Roberto de Mezerville (Age 43)Chief Technology Officer Mr. Salvador Santos Dada (Age 42)Head of Special Projects Comp: $468.62kMs. Rosalyn Cole d'IncelliSVP of Global Clinical, Medical & US Regulatory AffairsMs. Elizabeth Panzica NewmanVP & Head of U.S Business UnitMr. Ivan BilicSenior Vice President of Commercial Operations - OUSMs. Neeta TopraniCorporate SecretaryMore ExecutivesKey CompetitorsEargoNASDAQ:EARAvanos MedicalNYSE:AVNSJin Medical InternationalNASDAQ:ZJYLInogenNASDAQ:INGNInvacareNYSE:IVCView All CompetitorsInsiders & InstitutionsRice Hall James & Associates LLCSold 12,889 shares on 4/23/2024Ownership: 2.688%Stableford Capital II LLCBought 30,815 shares on 4/10/2024Ownership: 0.113%Perceptive Advisors LLCSold 195,384 shares on 2/26/2024Ownership: 0.319%Iron Triangle Partners LPSold 238,888 shares on 2/14/2024Ownership: 1.283%Mudita Advisors LLPBought 47,284 shares on 2/13/2024Ownership: 0.552%View All Insider TransactionsView All Institutional Transactions ESTA Stock Analysis - Frequently Asked Questions Should I buy or sell Establishment Labs stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares. View ESTA analyst ratings or view top-rated stocks. What is Establishment Labs' stock price target for 2024? 5 brokerages have issued 12-month target prices for Establishment Labs' shares. Their ESTA share price targets range from $47.00 to $65.00. On average, they anticipate the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 13.3% from the stock's current price. View analysts price targets for ESTA or view top-rated stocks among Wall Street analysts. How have ESTA shares performed in 2024? Establishment Labs' stock was trading at $25.89 on January 1st, 2024. Since then, ESTA shares have increased by 87.5% and is now trading at $48.54. View the best growth stocks for 2024 here. Are investors shorting Establishment Labs? Establishment Labs saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 4,930,000 shares, an increase of 8.1% from the March 15th total of 4,560,000 shares. Based on an average daily trading volume, of 457,400 shares, the short-interest ratio is currently 10.8 days. Currently, 21.7% of the shares of the company are sold short. View Establishment Labs' Short Interest. When is Establishment Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our ESTA earnings forecast. How can I listen to Establishment Labs' earnings call? Establishment Labs will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.79) earnings per share for the quarter, beating the consensus estimate of ($0.95) by $0.16. The company earned $31.60 million during the quarter, compared to the consensus estimate of $31.44 million. Establishment Labs had a negative trailing twelve-month return on equity of 357.81% and a negative net margin of 47.53%. The business's quarterly revenue was down 27.9% on a year-over-year basis. During the same period last year, the business earned ($0.55) EPS. What ETFs hold Establishment Labs' stock? ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Establishment Labs issued on next quarter's earnings? Establishment Labs issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $174.0 million-$184.0 million, compared to the consensus revenue estimate of $173.7 million. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS). When did Establishment Labs IPO? Establishment Labs (ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Establishment Labs' stock is owned by a variety of institutional and retail investors. Top institutional investors include Rice Hall James & Associates LLC (2.69%) and Stableford Capital II LLC (0.11%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Raj Denhoy and Renee Gaeta. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ESTA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
